Freeze-dried Live Attenuated Hepatitis A Vaccine

Freeze-dried Live Attenuated Hepatitis A Vaccine is a live, weakened version of the Hepatitis A virus that has been developed to stimulate the immune system without causing an infection. This vaccine is used for the prevention of Hepatitis A, a viral infection that affects the liver and can cause severe illness, hospitalization, and even death.
Hepatitis A is primarily transmitted through the ingestion of contaminated food or water, close contact with an infected person, or through sexual activity. The vaccine provides long-lasting immunity, typically lasting over 20 years in most recipients.
The vaccine is recommended for individuals at high risk of Hepatitis A exposure, such as travelers to regions with high prevalence, those with impaired immune systems, men who have sex with men, injecting drug users, and children in communities with high rates of the disease. The vaccine is also provided to certain groups of the general population as part of routine vaccination programs, based on local public health recommendations.
The Freeze-dried Live Attenuated Hepatitis A Vaccine is administered as a single dose, usually given as an injection into the muscle. Side effects are generally mild and may include soreness at the injection site, fatigue, headache, and mild fever. These symptoms typically resolve within a few days.